SRZN

SURROZEN INC

SRZN·86889P208·US·Common Stock·Healthcare - Biotechnology-Activist

SRZN (SURROZEN INC) is held by 32 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($21.3M), Woodline Partners LP ($6.6M), BALYASNY ASSET MANAGEMENT L.P. ($5.9M). Net institutional sentiment: Mixed.

32
Holders
Avg rating(4 Elite)
$62.1M
Total Value
61% (40)
Fund Consensus
22 buying - 14 selling
SRZNSmart Money Verdict
View all
Held by 32 funds
4 elite
Who's Trading
ActivistCIThe Column Group III GP, LP23.6%May 18, 2026
ActivistBOBoxer Capital Management, LLC6.7%May 15, 2026
ActivistNANantahala Capital Management, LLC2.1%May 15, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.9.9%May 15, 2026
Activist5V5AM Partners VII, LLC9.5%May 15, 2026
ActivistSTStemPoint Capital LP4.5%May 15, 2026
InsiderLYLi YangSell $53KMay 4, 2026
InsiderWOWilliams Charles OSell $68KMay 4, 2026
InsiderPCParker Craig CSell $151KMay 4, 2026
InsiderPCParker Craig CExercise 13K shMay 1, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
731,138(+1.4%)$21.3M0.0%+15.16%
29
Decreased
227,848(-1.2%)$6.6M0.0%+19.03%
0
Increased
203,888(+7.0%)$5.9M0.0%+25.57%
29
New
169,092$4.9M0.0%-13.63%
37
Increased
159,711(+143.1%)$4.7M0.0%-6.00%
43
Unchanged
88,653$2.6M0.0%+81.22%
0
Decreased
71,697(-28.0%)$2.1M0.0%+7.61%
0
Decreased
65,849(-1.7%)$1.9M0.0%-15.98%
0
Increased
49,126(+117.1%)$1.4M0.0%+10.21%
41
New
39,482$1.2M0.0%-13.63%
35
Increased
35,469(+140.6%)$1M0.0%+15.95%
40
New
35,390$1M0.0%-13.63%
35
Increased
27,851(+6.6%)$811,2990.0%+37.48%
18
Increased
27,726(+14.0%)$807,6580.0%+32.92%
19
Increased
25,851(+0.1%)$753,0400.0%+7.58%
25
Unchanged
23,557$686,2150.0%+7.61%
0
Decreased
22,446(-39.3%)$653,8510.0%+100.26%
0
Unchanged
21,715$633,0000.0%+126.24%
0
Increased
21,247(+359x)$618,9250.0%-13.58%
39
Increased
18,930(+73.0%)$551,4310.0%-2.51%
36

Showing 1-20 of 40

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used